Cardiovascular Diseases Final

download Cardiovascular Diseases Final

of 119

Transcript of Cardiovascular Diseases Final

  • 8/8/2019 Cardiovascular Diseases Final

    1/119

    Major disorders of Circulatory

    System

  • 8/8/2019 Cardiovascular Diseases Final

    2/119

    general Nursing diagnosis

    for clients with circulatory system disorders

    A. Decreased cardiac output

    1) Excessive cardiac workload

    2) Decreased tissue perfusion

    3) Blood loss

    4) Decrease venous return

    B. Altered tissue perfusion rel to

    1) Decreased cardiac output

    2) Peripheral vasoconstriction or obstruction

    3) Inadequate, excessive, or ,inappropriate nutrition

    4) Venous stasis

  • 8/8/2019 Cardiovascular Diseases Final

    3/119

    general Nursing diagnosis

    for clients with circulatory system disorders

    C. high risk for activity intolerance rel to

    1. Decrease cardiac output

    2. Dec tissue perfusion

    3. Decreased oxygen-carrying capacity of blood

    4. PainD. In effective individual coping rel to type A personality

    E. Fear rel to questionable prognosis and potential disability

    F. Personal identity disturbance related to sick role

    G. Pain related to

    1. impaired tissue perfusion

    2. Operative trauma

    H. Sexual dysfunction related to fear, medication, and disease process

    I. Fluid volume Excess related to dec cardiac output

  • 8/8/2019 Cardiovascular Diseases Final

    4/119

    general Nursing diagnosis

    for clients with circulatory system disorders

    J. ineffective denial related to prognosis and dse.process

    K. Noncompliance related to denial of prognosis

    L. High risk of injury related to diagnostics andtherapeutics

    M. self care deficit related to imposedrestrictions

    N. Fatigue related to decreased cardiac outputand decreased oxygen-carrying capacity of theblood

  • 8/8/2019 Cardiovascular Diseases Final

    5/119

    general Nursing diagnosis

    for clients with circulatory system disorders

    O. High risk infection related to dse process treatment modalities

    P. Ineffective breathing pattern related to trauma of chest surgery

    Q. High risk for impaired skin integrity related to altered peripheral

    perfusionR. Fluid volume deficit related to blood loss

    S.Altered thought process related to decreased cerebral perfusion

    T.Altered nutrition, less than body requirements related to

    inadequate dietary intake

  • 8/8/2019 Cardiovascular Diseases Final

    6/119

    ncm102

  • 8/8/2019 Cardiovascular Diseases Final

    7/119

    Congenital heart disease (CHD)

    malformation of the heart or the large bloodvessels near the heart. "Congenital"speaks only to time, not to causation. Itmeans "born with" or "present at birth."

    Alternative names forCHD include:congenital heart defect, congenital heartmalformation, congenital cardiovascular

    disease, congenital cardiovascular defect,and congenital cardiovascularmalformation.

  • 8/8/2019 Cardiovascular Diseases Final

    8/119

    Incidence:the most frequent form of major birth defects innewborns affecting close to 1% of newborn babies(8 per 1,000). This figure is an underestimate sinceit does not include some common problems,namely: Patent ductus arteriosus in preterm babies (a temporary

    condition)

    Bicuspid (two cusps) aortic valve (the aortic valve usuallyhas three cusps or flaps)

    Mitral Valve prolapse (drooping of a heart valve) Peripheral pulmonary stenosis (narrowing of the lung

    vessels well away from the heart)

  • 8/8/2019 Cardiovascular Diseases Final

    9/119

    CONGENITALHEART DISEASE

    CHD

    EARLY CYANOSIS LATE CYANOSIS

    1. Transpositionof 1. Ventricular Septal Defect

    Great Vessels 2. Atrial Septal Defect

    2. Truncus Arteriosus 3. Patent Ductus Arteriosus

    3. TetralogyofFallot 4. Arterio-venous Malformation

    a. VSD

    b. Overridingofthe Aortac. Pulmonic Stenosis

    d. Rightventricularhypertrophy

  • 8/8/2019 Cardiovascular Diseases Final

    10/119

    Conditions

    Defects associated with dec pulmonary bld

    flow

    D

    efects associated with inc pulmonary bldflow

    Defects causing obstruction to cardiac

    chamber outflow

    Defects associated with mixing of saturated

    and desaturated blood

  • 8/8/2019 Cardiovascular Diseases Final

    11/119

    Defects associated with dec

    pulmonary bld flow

    Right to left shunting of blood due to presence of a defect and

    obstruction of pulmonary blood flow

    Obstructed pulmonary flow leads to higher right side heart pressure

    Some or most does not enter the pulmonary circulation anddoes not pick up oxygen in the lungs; instead blood is shunted

    to the left side of the heart

    Deoxygenated as well as oxygenated blood circulated to the

    body

    Cyanosis and hypoxemia present

    TOF

  • 8/8/2019 Cardiovascular Diseases Final

    12/119

    Defects associated with inc pulmonary

    bld flow

    Left to right shunting of blood across a septal

    defect or blood vessel

    Pulmonary overcirculation and increased workof ventricles

    Risk for heart failure

    A

    cyanotic ASD, VSD, PDA

  • 8/8/2019 Cardiovascular Diseases Final

    13/119

    Defects causing obstruction to cardiac

    chamber outflow

    Narrowing of outflow tract from heart to

    blood vessels

    Increased work of heart as it strains to pushblood out

    Risk for heart failure and poor cardiac output

    COA, PS, AS

  • 8/8/2019 Cardiovascular Diseases Final

    14/119

    Defects associated with mixing of

    saturated and desaturated blood

    Oxygenated and deoxygenated blood mixes in

    heart chambers

    Increased pulmonary blood flow due to defect Hypoxemia and cyanosis present, often severe

    Risk for poor cardiac output and risk for heart

    failure (HF) TGA, Truncus arteriosus

  • 8/8/2019 Cardiovascular Diseases Final

    15/119

    TGA

  • 8/8/2019 Cardiovascular Diseases Final

    16/119

    Early Cyanotic Disease

    Tetralogy of Fallot

    AffectedpatientsusuallyhavecyanosisofAffectedpatientsusuallyhavecyanosisof

    thelips andskin whenfeedingorcryingthelips andskin whenfeedingorcrying

  • 8/8/2019 Cardiovascular Diseases Final

    17/119

    Early Cyanotic Disease-

    Tetralogy of Fallot

    COMPONENTS:COMPONENTS:

    1.1. VSDVSD

    (Ventriculoseptal(Ventriculoseptal

    defect)defect)

    2.2. Overriding of theOverriding of the

    AortaAorta

    3.3. Pulmonic stenosisPulmonic stenosis

    4.4. RVH (RightRVH (Right

    ventricularventricular

    hypertrophy)hypertrophy)

  • 8/8/2019 Cardiovascular Diseases Final

    18/119

    Late Cyanotic Disease-

    Atrial/ Ventricular Septal Defect

    ASDASD -- due to incompletedue to incomplete

    separation of the atriaseparation of the atria

    VSDVSD abnormal opening of theabnormal opening of the

    membranous or muscular portion ofmembranous or muscular portion of

    the ventricular septumthe ventricular septum

  • 8/8/2019 Cardiovascular Diseases Final

    19/119

    Late Cyanotic Disease-

    Patent DuctusArteriosus

    -- FailureoftheductusFailureoftheductusarteriosustoclosearteriosustoclose

    after birth,thusthereafter birth,thusthere

    is a connectionis a connection

    betweenthe aorta andbetweenthe aorta and

    the mainorleftthe mainorleftpulmonary arterypulmonary artery

  • 8/8/2019 Cardiovascular Diseases Final

    20/119

    COARCTATION OF THEAORTA

    Narrowing of thearch of the aortabeyond the originof the leftsubclavian artery.

    BP readings arehigher in the upperextremitiescompared to thelower.

  • 8/8/2019 Cardiovascular Diseases Final

    21/119

    ValvularHeart Disease:

    Aortic Stenosis

    --PathologicPathologic

    narrowing of thenarrowing of theaortic orificeaortic orifice

    --May lead to leftMay lead to left

    ventricularventricularhypertrophyhypertrophy

  • 8/8/2019 Cardiovascular Diseases Final

    22/119

    ValvularHeart Disease:

    Mitral Stenosis

    -- PathologicnarrowingPathologicnarrowing

    oftheorificeoftheoftheorificeofthe

    mitralvalvemitralvalve

  • 8/8/2019 Cardiovascular Diseases Final

    23/119

    ValvularHeart Disease:

    Mitral Valve Prolapse

    --AKA Floppy mitral valve,AKA Floppy mitral valve,

    clickclick--murmur syndrome,murmur syndrome,

    Barlow syndromeBarlow syndrome

    --Prolapse of one or bothProlapse of one or both

    cusps of the mitral valve intocusps of the mitral valve into

    the left atrium leading tothe left atrium leading to

    regurgitationregurgitation

  • 8/8/2019 Cardiovascular Diseases Final

    24/119

    Nursing care for Infants with Cardiac

    malformation

    Assessment:

    color: cyanosis pallor

    Apical pulse, peripheral pulses, presence of

    murmurs

    Respirations, dyspnea, frequency of colds

    Blood pressure

    Chest abnormalities

  • 8/8/2019 Cardiovascular Diseases Final

    25/119

    Nursing care for Infants with Cardiac

    malformation

    Analysis/ Nursing diagnoses

    1. activity intolerance related to imbalance between oxygen supplyand demand

    2. Decrease cardiac output related to structural defect

    3. Altered growth and development related to inadequate oxygenand nutrients to tissues and limited socialization with peers

    4. High risk for infection due to debilitated physical status

    5. Altered family processes related to having child with heartcondition

    6. High risk for injury complications) related to cardiac conditionsand therapies

  • 8/8/2019 Cardiovascular Diseases Final

    26/119

    Nursing care for Infants with Cardiac

    malformation

    Analysis and Diagnosis

    7. Body image disturbance related to having physical

    defect

    8. Social isolation related to inability to participate

    in active play

    9. High risk for caregiver role strain related to caring

    for ill child

  • 8/8/2019 Cardiovascular Diseases Final

    27/119

    Nursing care for Infants with Cardiac

    malformation

    Planning/Implementation

    Correctly calculate dosage ofDigoxin; usually prescribed in

    micrograms (1000 ug = 1mg)

    Take the apical pulse prior to administering ofDigoxin or drug

    Observe for sign of digitalis toxicity

    Teach parent the proper home administration ofDigoxin

    Help patient cope with symptoms of the disease

    Foster growth promoting family relationships

    Preoperative assessment areas necessary for planningpostoperative care

    Prepare child emotionally and physically for the surgery

  • 8/8/2019 Cardiovascular Diseases Final

    28/119

    Cardiac Surgery

    Surgical correction of

    congenital defects

    within the heart or

    surgery of the greatvessels in the

    immediate area

    surrounding theheart

  • 8/8/2019 Cardiovascular Diseases Final

    29/119

    Open-heart surgery- uses

    cardiopulmonary bypass;provides a relatively blood free

    operative site; heart-lung

    machine maintains gas exchange

    during surgery

    Closed-heart surgery does notuse cardiopulmonary bypass

    machine; indicated for ligation

    of a patent ductus arteriosus or

    COA

  • 8/8/2019 Cardiovascular Diseases Final

    30/119

    Nursing Interventions

    Determine the childs level of understanding;

    drawing a picture or tell a story

    Correct misunderstandings/teach the child about

    the surgery using a diagrams and play therapy

    Accompany the child to the OR and RR

    Have child practice post-op procedures

    Include parents in teaching sessions

    Establish pre-op baseline data for VS

  • 8/8/2019 Cardiovascular Diseases Final

    31/119

    Post-op

    Prevent injury/complicationsVS, ECG, neurosurgical site

    Promote gas exchange

    I & O

    Provide nutrition

    Psychologic support of the child/family

    Allow activity

    Provide client teaching and discharge planning

  • 8/8/2019 Cardiovascular Diseases Final

    32/119

    Blood dyscrasias

  • 8/8/2019 Cardiovascular Diseases Final

    33/119

    Sickle CellAnemia (SCA)

    AR disorder

    genetically recessive, meaning

    that one must have inherited a

    defective copy of the gene from

    both parents to develop thedisorder.

    form of iron deficiency caused

    by an abnormality in the way

    hemoglobin proteins form.

    Instead of the saucer-likeshape of normal red blood

    cells, these cells are crescent-

    or sickle-shaped.

  • 8/8/2019 Cardiovascular Diseases Final

    34/119

    SCA-

    Classification & Pathophysiology

    Sickle-shaped red blood cells are unable tocarry oxygen as well as normal cells, leadingto a condition that causes many of thesymptoms of acquired iron deficiencyanemia. However, this disease carries theadded risk of blood clots since the abnormallyshaped cells are more likely to stick to eachother and the walls of the blood vessels.

    Types Homozygous SCA

    Heterozygous SCA

  • 8/8/2019 Cardiovascular Diseases Final

    35/119

    SCA-

    clinical findings

    Vaso-occlusive Crisis

    Most common and only painful type

    Results from sickled cells obstructing BV leading

    to occlusion, ischemia, and potential necrosis

    Blockage causes the blood viscosity to increase,

    producing sludging and resulting in further

    hypoxia and increased sickling

    S/S: fever, acute abdominal pain, hypoxia, Hand-

    foot syndrome, arthralgia without an exacerbation

    of anemia

  • 8/8/2019 Cardiovascular Diseases Final

    36/119

    SCA-

    clinical findings

    Splenic sequestration crisis

    Results from the spleen pooling largequantities of blood in spleen, which causes a

    precipitous drop in BP and ultimately to shockACUTE episodes:

    Most common in 8mos to 5 y/o

    Can result to death due to anemia and CVS

    collapse CHRONIC states

    functional ASPLENIA

  • 8/8/2019 Cardiovascular Diseases Final

    37/119

    SCA-

    clinical findings

    Aplastic Crisis- diminished RBC production

    Maybe triggered by viral or other infection

    Profound anemia results from rapid destruction of

    RBC combined with decreased production

    Hyper-hemolytic Crisis

    S/S: anemia jaundice and reticulocytosis ARare cases and suggests a coexisting abn.

    such as G6PD

  • 8/8/2019 Cardiovascular Diseases Final

    38/119

    SCA-

    therapeutics

    Unfortunately, simply increasing the dietary iron intake will

    not help individuals with this disease.

    There is currently no cure, but there is hope that through

    persistent research, a cure can be found.

    Currently, people with sickle-cell disease can be treated

    with a host of drugs that alleviate symptoms and prevent

    opportunistic infections that arise as a result of a weakened

    immune system.

    A 1999 report in the Journal of theAmerican MedicalAssociation (JAMA) described in vitro fertilization

    techniques can prevent the disease from being handed

    down to offspring.

  • 8/8/2019 Cardiovascular Diseases Final

    39/119

    SCA-

    therapeutics

    1. prevention of sickling phenomenon Adequate oxygenation

    Adequate hydration

    2.treatment of crisis Rest

    Hydration/ electrolyte replacement

    Pain mngt

    Antibiotic therapy

    Blood products: transfusion therapy RBC

  • 8/8/2019 Cardiovascular Diseases Final

    40/119

    SCA

    NSG care

    1.mngt of pain Use of analgesia

    Joint swelling: elevation of body part

    Relaxation/breathing techniques/distraction Physical therapy, whirlpool baths, transcutaneousnerve stimulation (TENS)

    2.mngt of infection Nsg care focus : ID of s/s of infection

    Home medications: advise pt for compliance ofthe whole therapy

    3. Promote coping skills

  • 8/8/2019 Cardiovascular Diseases Final

    41/119

    SCA

    NSG care

    Monitoring and managing Complications

    1. Leg ulcers: Wound ostomy-continencenurse

    2. Priapism leading to impotence` Advise pt to empty his bladder at the onset of the

    attack, exercise and take a warm bath

    ` Persistence of symptoms needs immediate

    medical attention-IV hydartion, analgesia.Possible intracavernosal aspiration

    3. Chronic pain and substance abuse

  • 8/8/2019 Cardiovascular Diseases Final

    42/119

    Hemophilia

    Blood clotting disorder; Genetic : X-linked

    Recessive transmission; males

    Types: Hemophilia typeA : Factor VIII deficiency;

    Classic Hemophilia ;More common

    Hemophilia type B: Factor IX def.; Christmas Hemophilia

  • 8/8/2019 Cardiovascular Diseases Final

    43/119

    Hemophilia-

    clinical findings

    Prolonged bleeding from any wound

    Hemarthrosis: bleeding into the joints; resulting in pain;deformity and retarded growth

    Intracranial hemorrhage

    Anemia

    Severity of bleeding

    severity F8 activity Remarks

    Mild 5-50% Bleeding with sever trauma

    or SxModerate 1-5% Bleeding with trauma

    Severe

  • 8/8/2019 Cardiovascular Diseases Final

    44/119

    Hemophilia-

    therapeutics

    1. Control of bleeding

    2. Prevention of bleeding with the use of

    factor replacementa. Drugs that replace deficient coagulationfactors

    a) Factor 8 concentrate

    Obatained from human sources and provides good sourceof concentarted F8

    b) Factor 9 complex: contains F2, F7, F9, F10conc

  • 8/8/2019 Cardiovascular Diseases Final

    45/119

    Hemophilia-

    therapeutics

    a. Adjunctive measures

    a) Aminocaproic acid (Amicar): inhibits the enzyme

    that destroys fromed fibrin and inc fibrinogen

    activity in clot formationb) Fibrinogen: maintains plasma fibrinogen levels

    required for clotting materials

    c) Thrombin: supplies physiologic levels of natural

    material at superficial bleeding sites to control

    beeding

  • 8/8/2019 Cardiovascular Diseases Final

    46/119

    Hemophilia-

    NSG Care

    1. ASSESSMENT:

    a. Parent/child knowledge of disease process and injuryprevention

    b. Joint bleeding

    c. Mobility of joints2. ANALYSIS/NSG DX

    a. High risk for injury (hemorrhage) related to deficient bloodclotting

    b. Pain related to bleeding into joints/tissues

    c. Impaired mobility rel to effects of hemorrhages into joints andtissues

    d. Altered family processes rel to situational crisis

    (child with chronic disease)

  • 8/8/2019 Cardiovascular Diseases Final

    47/119

    Hemophilia-

    NSG Care

    2. ANALYSIS/NSG DX

    e. Knowledge deficit rel to

    1) Disease process, home mngt., activity limitations

    f. Body image disturbance related to

    1) Perception of self as a different

    2) Inability to participate

    g. Body image disturbance rel to1) Perception of self as different

    2) Inability to participate in selected activities

  • 8/8/2019 Cardiovascular Diseases Final

    48/119

    Hemophilia-

    Planning /implementation

    1. Instruct the child and parents in the tx of thebleeding, esp the joints

    1. Immobilization of the area

    2. Compression of the area

    3. Elevation of the body part

    2. Provide appropriate activity that lessens thechance of trauma, which is often difficultbcoz boys are physically active

    3. Select safe toys; inform parents to safe-proof house to minimize injuries

    4. Avoid use of aspirin or ibuprofen

  • 8/8/2019 Cardiovascular Diseases Final

    49/119

    Hemophilia-

    Planning /implementation

    Control joint pain so the child to prevent

    muscle atrophy

    Provide counseling about geneticpredisposition

    Encourage parents to treat the child as

    normally as possible, avoiding

    overprotection and over permissiveness

  • 8/8/2019 Cardiovascular Diseases Final

    50/119

    Kawasaki DSE

    Aka: MUCOCUTANEOUS LYMPH NODESYNDROME

    Acute febrile illness of unknown cause; the

    principal area of involvement iscardiovascular system with extensiveperivasculitis of arterioles, venules, andcapillaries, incl the coronary arteries,panvasculitis of arterioles

    Classification; common among japanese,then blacks, then caucasians

    Geograhic and seasonal outbreaks

  • 8/8/2019 Cardiovascular Diseases Final

    51/119

    Kawasaki Disease-

    clinical findings

    Fever for more than 5 days

    Bilateral congestion of ocular conjunctiva without exudation

    Changes is mucous membranes of the oral cavity such as

    erythema, dryness, and fissuring of the lips, orpharyngeal

    reddening orstrawberry tongue

    Changes in extremities, such as peripheral edema,

    erythema and desquamation of palms and soles,

    particularly the periungal peeling

    Polymorphous rash, primarily the trunk Cervical LAD

  • 8/8/2019 Cardiovascular Diseases Final

    52/119

    Kawasaki Disease-

    therapeutics

    Primarily supportive and directed toward

    controlling fever, preventing dehydration

    and minimizing possible cardiac

    complications

    Large doses of aspirin

    IV gamma globulin

    Monitoring cardiac status

  • 8/8/2019 Cardiovascular Diseases Final

    53/119

    Kawasaki Dse-

    planning and implementation

    to control fever:Administer aspirin

    To control joint pains

    Observe for allergic reaction to and side

    effects of IV gamma globulin Monitor for signs of heart disease, especially

    arrhythmias

    See general Nursing Care of preschoolers

    with health problems See meeting the needs of the family of thechild with disability

  • 8/8/2019 Cardiovascular Diseases Final

    54/119

    Kawasaki Disease-

    Evaluation and outcome

    Parents and child can discuss concerns

    about illness

    Child exhibits no sign of impaired skin

    Child does not report the presence of pain

  • 8/8/2019 Cardiovascular Diseases Final

    55/119

    Rheumatic Fever

    Collagen disease: characterized by damaged connectivetissue and usually blood vessels

    Classification: Autoimmune reaction to GABHS pharyngitis Self-limited involves joint: involves joints, skin brain

    Clinical Findings Heart: Mitral and aortic stenosis occur Joints: edema, inflammation and effusion esp. in the knees,

    elbows, joints hips, shoulder and wrist Skin: erythema, macular with clear center and wavy

    demarcated border usually on the trunk and proximalextremeties

    Neorologic: chorea Low-grade fever, epistaxis, abdominal pain, arthralgia,

    weakness, fatigue, pallor, anorexia and weight loss

  • 8/8/2019 Cardiovascular Diseases Final

    56/119

    Assessment Findings

    Major symptoms (J

    ones Criteria) Carditis cardiomegaly, Aschoff nodules (areas of

    inflammation and degeneration around heart valves,

    pericardium, and myocardium), valvular insufficiency of

    mitral and aortic valves; SOB, hepatomegaly, edema

    Polyarthritis migratory, large joints become red, swollen

    and painful

    Chorea (Sydenhams chorea, St Vitus dance) CNS

    disorder char by abrupt, purposeless, involuntary muscular

    movements

  • 8/8/2019 Cardiovascular Diseases Final

    57/119

    Subcutaneous nodules

    usually a sign of severedisease; occurs with active

    carditis; firm, nontender, no

    lesion bony prominences of

    joints

    Erythema marginatum

    transient nonpruritic rash

    starting with central red

    patches that expand

  • 8/8/2019 Cardiovascular Diseases Final

    58/119

    Minor symptoms

    Reliable history of RF,

    Fever

    Arthralgias

    Recent history of strep infection Diagnostic tests: antistreptolysin O (ASO) titer

    increased

    Elevated Sedimentation Rate (ESR)

    Elevated C- reactive protein

    Prolonged PR Interval on Electrocardiogram

  • 8/8/2019 Cardiovascular Diseases Final

    59/119

    Diagnostic criteria

    Two Major Criteria or

    One Major and 2 Minor Criteria

  • 8/8/2019 Cardiovascular Diseases Final

    60/119

    Rheumatic Fever

    Therapeutics

    Antibiotic therapy to eradicate the organismand preventing recurrence Penicillin used prophylactically to prevent future

    attacks of strep and further damage to the heart

    To be taken until age 20 or for 5 years after attack,whichever is longer

    Arhtritis - aspirin

    Chorea decrease stimulation; provide a

    safe environment Prevention of permanent cardiac damage

    Palliation of other symptoms

  • 8/8/2019 Cardiovascular Diseases Final

    61/119

    Rheumatic Fever

    NSG Care

    Assessment Child/parent compliance with drug regimen

    Symptoms development

    Nutritional intake

    Activity level

    Analysis and Diagnosis High risk for injury rel to autoimmune system

    Decrease cardiac output rel to disease process

    Altered nutrition: less than the body requirements Rel to anorexia/ fatigue

    High risk for impaired skin integrity rel to disease process

    Impaired physical mobility Pain related to inflammation of the joints

    Fatigue related decreased cardiac output

    Activity tolerance

  • 8/8/2019 Cardiovascular Diseases Final

    62/119

    Rheumatic Fever

    NSG Care

    Planning and implementation1. Encourage bed rest and reduce work load of the heart

    2. Encourage child to do schoolwork and keep with the class

    3. Stimulate the development of quiet hobbies and collections

    4. Gradually increase activities over a period of weeks to

    months

    5. Handle painful joins carefully

    6. Maintain proper body alignment to prevent deformities

    7. Monitor for pain medication and administer when necessary8. Encourage an increase intake of Nutritious food

    9. Provide small frequent. nutrional

  • 8/8/2019 Cardiovascular Diseases Final

    63/119

    YoungAdult

    Cardiac Diseases Hodgkins Disease

    Infectious Mononucleosis

    Pericarditis

    Myocarditits

    Endocarditis

  • 8/8/2019 Cardiovascular Diseases Final

    64/119

    Hodgkins Disease

    Etio: unknown

    Higher incidence among male and youngadults

    Proliferation of malignant cells (ReedSternberg cells ) within the Lymph nodes

    All tissues may eventually be involved butchiefly lymph node, spleen, liver, tonsils andbone marrow

    Classification by staging and the presence orabsence of systemic symptoms

  • 8/8/2019 Cardiovascular Diseases Final

    65/119

    Hodgkins Disease-

    clinical Findings

    Dyspnea and dysphagia caused by pressure from theenlarge nodes

    Pruritus

    Anorexia

    Enlarged LN (generally cervical LN are involved first Diagnosis confirmed by histologic examination of a lymphnode

    Progressive anemia

    Elevated temperature

    Enlarged spleen and liver may occur Pressure from the enlarged LN may lead to edema andobstructive jaundice

    thrombocytopenia

  • 8/8/2019 Cardiovascular Diseases Final

    66/119

    Hodgkins Disease-

    therapeutics

    Staging procedures include: CBC, liver fxnstudies ; CT thorax and abdomen; bonemarrow and lymph node biopsies;lymphangiography

    Radiotherapy Vital organs must be shielded

    Potential side effects: nausea, skin rashes; drymouth, dysphagia

    Surgical intervention includes excision ofmasses to relieve pressure on the otherorgans

  • 8/8/2019 Cardiovascular Diseases Final

    67/119

    Hodgkins Disease-

    therapeutics

    Chemotherapy Nitrogen mustard Thiophosphoramide Chlorambucil

    Vincristine Doxorubicine Prednisone Procarbazine hydrochloride Bleomycin

    Vinblastine Dacarbazine MOPP andABVD protocols

  • 8/8/2019 Cardiovascular Diseases Final

    68/119

    Hodgkins Disease-

    NSG care

    Assessment

    LN to determine enlargement

    Temperature for baseline data

    Liver and spleen to determine enlargenment

    Analysis and Diagnosis

    Refer to the general Nursing diagnosis for

    clients with circulatory system disorders

  • 8/8/2019 Cardiovascular Diseases Final

    69/119

    Hodgkins Disease-

    NSG care

    Planning and implementation Provide emotional support for the client and

    family

    Protect from infection

    Monitor infection Monitor temperature

    Observe for signs of anemia; provide adequaterest

    Examine sclera and skins for signs of jaundice Encourage high nutrient density foods; observe

    for anorexia and nausea

  • 8/8/2019 Cardiovascular Diseases Final

    70/119

    Hodgkins Disease-

    NSG care

    Evaluation and outcomes

    Remains afebrile

    Conserves energy

    Verbalizes feelings related to therapy and

    prognosis

    Continues supervision

  • 8/8/2019 Cardiovascular Diseases Final

    71/119

    Infectious Mononucleosis

    Acute infectious disease of the lymphaticsystem

    caused by Epstein barr Virus

    MOT: respiratory droplets Incubation period: uncertain; probably 28-

    42D

    Incidence: high among 15-35 years old

    Complication: hepatitis, ruptured spleen,pericarditis and meningoencephalitis

  • 8/8/2019 Cardiovascular Diseases Final

    72/119

    Infectious Mononucleosis

    clinical manifestation

    Sore throat, malaise, stiff neck, nausea

    Elevated temp, enlarged tenderLN (esp those atthe cervical nodes involved first)

    Splenomegaly in approximately 50% of the clients Elevated lymphocytes and monocytes counts

    Positive heterophile antibody agglutination test

  • 8/8/2019 Cardiovascular Diseases Final

    73/119

    Diagnosis of infectious mononucleosis

    requires the evaluation of clinical symptoms andhematologic and serologic laboratory testresults.

    Hematologic studies reveal a normal to

    increased white blood cell count, decreasedsegmented neutrophils, and markedlyincreasedreactive lymphocytes.

    Serologic tests include assays for heterophileantibodies and assays for antibodies specific for

    EBV. In about 85% of IM cases, patients produce IgM

    heterophile antibodies.

  • 8/8/2019 Cardiovascular Diseases Final

    74/119

    A heterophile antibody is an antibody that willreact with an antigen other than the antigen forwhich it was produced.

    In the case of infectious mononucleosis, the

    patient produces heterophile antibodies whichmay react with the erythrocytes of sheep, beef,oxen, or horses.

    Heterophile antibodies are detectable about oneweek after infection, peak at 2 to 4 weeks, anddecrease to undetectable levels at about 12weeks.

  • 8/8/2019 Cardiovascular Diseases Final

    75/119

    Infectious mononucleosis

    Nursing Care

    Assessment: Temperature for baseline data

    History of lethargy and fatigue

    Cervical Lymphadenopathy Hepatosplenomegaly

    Inflammation of the throat-swelling, grayish whiteexudate in the tonsils

    Analysis/Nursing Refer to General Nursing diagnosis for clients

    with circulatory Disorder: N, O

  • 8/8/2019 Cardiovascular Diseases Final

    76/119

    Infectious mononucleosis

    Nursing Care

    Planning and Implementation Provide rest Administer aspirin as ordered Assess for signs of complications; spleen should

    not be palpated once the diagnosis is made Increase fluid intake Support natural defense mechanism; encourage

    intake of foods rich in immune stimulatingnutrients, esp. VitaminA,C E, minerals: seleniumand zinc

    Evaluation: Fatigue is reduced Afebrile state is maintained

  • 8/8/2019 Cardiovascular Diseases Final

    77/119

    Inflammatory diseases of the heart

    Pericarditis

    Myocarditis

    Infective Subacute endocarditis

  • 8/8/2019 Cardiovascular Diseases Final

    78/119

    Pericarditis

    Etio: bacterial (streptococcus,staphylococcus, gonococcus,meningococcus, Viral (coxakie, influenza),

    Mycotic(Fungal), rickettsial, parasitic, trauma,collagen disease, rhematic fever, neoplasticdisease

    Sequelae

    Loss of pericardial elasticity or accumulation offluid within the sac

    Heart failure or cardiac tamponade

  • 8/8/2019 Cardiovascular Diseases Final

    79/119

    Pericarditis, acute

    Central chest pain aggravated by coughing,inspiration and recumbency

    Pericardial friction rub on ausculation

    Characteristic ECG changes Treatment: Treat underlying cause

    NSAIDs

    Steriods are used for unresponsive to NSAIDs

    Cochicine for recurrenct episodes

    Pericardiectomy in rare cases

  • 8/8/2019 Cardiovascular Diseases Final

    80/119

    Pericarditis, constrictive

    Constrictivepericarditis: scarring and

    calcificationofthepericardium as a

    lateconsequenceofinflammation

  • 8/8/2019 Cardiovascular Diseases Final

    81/119

    Pericarditis, Constrictive

    Markedly elevated jugular venous pressure

    With accentuated x and y descents andKaussmul sign

    Pericardial knock on auscultation MRI, CT or ECHo imaging shows thickened

    pericardium

    Treatment Surgical Pericardiectomy

    A low cardiac output state may occur after surgerybcoz myocardial atrophy from long termcompression and may require prolonged pressortherapy

  • 8/8/2019 Cardiovascular Diseases Final

    82/119

    PERICARDITIS WITH EFFUSION Inflammation of the pericardium accompanied by fluid

    accumulation in the pericardial sac.

    Dyspnea, orthopnea

    Palpitations, cough

    Dysphagia

  • 8/8/2019 Cardiovascular Diseases Final

    83/119

    Myocarditis

    Inflammationofthe myocardiumInflammationofthe myocardium

    Etiology:Etiology:

    viruses (Coxsackie B), bacteria,viruses (Coxsackie B), bacteria,

    chemicals, radiationetc.chemicals, radiationetc.

    RheumaticfeverRheumaticfever

    EndocarditicdseEndocarditicdse

    SequelaeSequelae

    ImpairedcontractilityoftheheartImpairedcontractilityoftheheart

    caused byinflammatoryprocesscaused byinflammatoryprocess

    Myocardialischemia andMyocardialischemia and

    necrosisnecrosis

    Endocarditis

  • 8/8/2019 Cardiovascular Diseases Final

    84/119

    Endocarditis

    Subacute Bacterial Endocarditis

    ENDOCARDITISENDOCARDITIS

    inflammation of theinflammation of the

    endocardium usually involvingendocardium usually involving

    the valvesthe valves

    SUBACUTE BACTERIALSUBACUTE BACTERIAL

    ENDOCARDITISENDOCARDITIS

    -- occurs in an abnormal valveoccurs in an abnormal valve

    -- Underlying cause could beUnderlying cause could bedue rheumatic heart disease,due rheumatic heart disease,

    congenital heart disease,congenital heart disease,

    MVP or previous valveMVP or previous valve

    surgerysurgery

    I fl t Di Of Th H t

  • 8/8/2019 Cardiovascular Diseases Final

    85/119

    Inflammatory Diseases Of The Heart

    Therapeutic interventions

    Oxygen therapy, Bed rest,

    antibiotic to relive underlying infection

    Corticosteroids, anti-dysrhythmias Pericardiectomy

    Salicylates to suppress rheumatic activity

    Cardiac monitoring

    I fl t Di Of Th H t

  • 8/8/2019 Cardiovascular Diseases Final

    86/119

    Inflammatory Diseases Of The Heart

    NSG care

    Assessment

    Signs of shock, heart failure and dysrhythmias

    Temperature for baseline data

    Distention of neck veins, friction rub andmurmur

    Overt and covert indicators of pain

    Analysis/Nursing diagnosis

    Refer to General Nursing diagnosis for clientswith circulatory Disorder:A1 B1 C E N O

    I fl t Di Of Th H t

  • 8/8/2019 Cardiovascular Diseases Final

    87/119

    Inflammatory Diseases Of The Heart

    NSG care

    Planning and implementation Maintain tranquil environment and help the client

    achieve the maximum rest

    Medicate for discomfort as needed

    Allow expression of concerns Explain post-hospitalization therapy to improve

    compliance

    Administer antibiotics as ordered

    Monitor temperature and blood cultures todetermine the effect of antibiotic therapy

    If Sx is undertaken, care for chest tubes andfollow post operative chest surgery routine

  • 8/8/2019 Cardiovascular Diseases Final

    88/119

    ADULT CARDIACDISEASES

    Atherosclerosis

    Coronary Heart Disease

    Angina Pectoris

    Myocardial Infarction

    Hypertension Peripheral Vascular diseases

    Across the life span

    Anemia

    Leukemia

    DIC

  • 8/8/2019 Cardiovascular Diseases Final

    89/119

    Arteriosclerosis; Hardening of the arteries;Plaque buildup arteries

    Definition Atherosclerosis is a condition in which fatty

    material collects along the walls of arteries. Thisfatty material thickens, hardens, and mayeventually block the arteries.

    Atherosclerosis is a type of arteriosclerosis. Thetwo terms are often used to mean the same thing.

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    90/119

    Atherosclerosis

    Causes and incidence,

    Atherosclerosis is a common disorder of the arteries. It occurs whenfat, cholesterol, and other substances build up in the walls of arteriesand form hard substances called plaque.

    Eventually, the plaque deposits can make the artery narrow and lessflexible. This makes it harder for blood to flow. If the coronary

    arteries become narrow, blood flow to the heart can slow down orstop, causing chest pain (stable angina), shortness of breath, heartattack, and other symptoms.

    Pieces of plaque can break apart and move through thebloodstream. This is a common cause of heart attack and stroke.Blood clots can also form around the plaque deposits. Clots block

    blood flow. If the clot moves into the heart, lungs, or brain, it cancause a stroke, heart attack, or pulmonary embolism.

  • 8/8/2019 Cardiovascular Diseases Final

    91/119

    risk factors

    Risk factors for atherosclerosis include: Diabetes

    High blood pressure

    High cholesterol

    High-fat diet

    Obesity Personal or family history of heart disease

    Smoking

    The following conditions have also been linked toatherosclerosis:

    Cerebrovascular disease Kidney disease involving dialysis

    Peripheral vascular disease

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    92/119

    Atherosclerosis

    clinical Manifestation

    More common symptoms of coronary heart disease include thefollowing. No one person usually has all of these symptoms.

    Chest pain on exertion (angina pectoris), which may be relieved byrest

    Shortness of breath on exertion

    Jaw pain, back pain, or arm pain, especially on left side, eitherduring exertion or at rest

    Palpitations (a sensation of rapid or very strong heart beats in yourchest)

    Dizziness, light-headedness, or fainting

    IrregularHeartbeat

    Weakness on exertion or at rest Silent ischemia is a condition in which no symptoms occur eventhough an electrocardiogram (ECG, or heart tracing) and/or othertests show evidence of ischemia.Arteries may be blocked 50% ormore without causing any symptoms.

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    93/119

    Atherosclerosis

    clinical Manifestation

    Diaphoresis

    BP elevation

    Signs of underlying disease maybeevident (cardiomegaly, valvular disease,

    dysrythmias)

    ECG recordings: varied in different

    activities

    ECG often reveals previous infarction

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    94/119

    Atherosclerosis

    Diagnostics

    Tests that may be used to diagnoseatherosclerosis or complications include:

    Ankle/brachial index (ABI)

    Arteriography Cardiac stress testing

    CT scan

    Doppler study

    Intravascular ultrasound (IVUS)

    Magnetic resonance arteriography (MRA

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    95/119

    Atherosclerosis

    Therapeutic Intervention

    Restricted activity

    Pharmacologic mngt. Aspirin: When taken daily or every other day, aspirin reduces

    the risk of developing angina or heart attack by reducing thetendency of your blood to clot.

    It reduces the chance that a clot will form over a rupturingplaque in the coronary artery, a common underlyingphenomenon in heart attack (myocardial infarction).

    Side effects of aspirin include ulcers or bleeding problems.

    Talk to your health care provider before starting aspirin.

    Beta-blockers - Beta-blockers decrease your heart rate and

    blood pressure, thus reducing your hearts demand foroxygen. Clinical trials have shown prevention of future heartattacks and sudden death.

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    96/119

    Atherosclerosis

    Therapeutic Intervention

    Nitroglycerin: This medication reduces chest painboth by decreasing your hearts oxygen demandand by dilating the coronary arteries, increasingthe oxygen supply.

    Sprays or tablets placed under your tongue aredesigned to be taken when you need instant relief fromangina.

    Long-acting nitroglycerin tablets or skin patches workslowly over many hours.

    Calcium channel blockers - Calcium channel

    blockers dilate the coronary arteries to improveblood flow. They also reduce blood pressure, andslow heart rate.

  • 8/8/2019 Cardiovascular Diseases Final

    97/119

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    98/119

    Atherosclerosis

    NSG care

    Assessment Vital signs, activity tolerance

    History of precipitating factors

    Analysis/Nsg diagnosis Refer to General Nursing diagnosis for clients with circulatory

    System disorder A1,C2, E, F

    Planning and Implementation Provide physical and mental rest

    Relieve pain by administration of vasodilators

    Discourage smoking Educate clients regarding diet medication and activity

    Provide necessary emotional support to clients regardingalteration in life style

    Atherosclerosis

  • 8/8/2019 Cardiovascular Diseases Final

    99/119

    Atherosclerosis

    Evaluation/Outcomes

    Describe the use of therapeutic

    medications

    Alters life style, which contributes to

    improvement in the disease process

    Episodes of pain are decreased in

    frequency, duration, and intensity

    Coronary Artery Disease:

  • 8/8/2019 Cardiovascular Diseases Final

    100/119

    CoronaryArtery Disease:

    Angina Pectoris

    --EpisodicprecordialorEpisodicprecordialor

    substernalchestpainduetosubsternalchestpaindueto

    inadequate bloodsupplyforinadequate bloodsupplyfor

    myocardialoxygenationmyocardialoxygenation

    STABLESTABLE chestpainchestpainprecipitated byexertion,precipitated byexertion,

    relieved by restrelieved by rest

    VARIANT/PRINZMETALVARIANT/PRINZMETAL

    chestpain at rest,duetochestpain at rest,dueto

    coronary arteryspasmcoronary arteryspasm

    UNSTABLEUNSTABLE longerlonger

    duration,severesymptoms,duration,severesymptoms,

    must ruleout MYOCARDIALmust ruleout MYOCARDIAL

    INFARCTINFARCT

    CoronaryArtery Disease:Angina Pectoris

  • 8/8/2019 Cardiovascular Diseases Final

    101/119

    Patterns of Ischemic Heart Disease (IHD)

    Angina pectoris - a symptom complex of IHD characterized by

    paroxysmal attacks of chest pain, usually substernal or precordial,caused by myocardial ischemia that falls short of inducinginfarction. There are several patterns:

    1. Stable angina (typical) - paroxysms of pain related to exertion andrelieved by rest or vasodilators. subendocardial ischemia with ST-segment depression

    2. Variant or Prinzmetal's angina - angina that classically occurs atrest and is caused by reversible spasm in normal to severelyatherosclerotic coronary arteries. ST-segment elevation ordepression maybe seen during attacks.

    3. Unstable angina - prolonged pain, pain at rest in a person withstable angina, or worsening of pain in stable angina. ST-segmentdepression (usually) and ST-segment elevation.

    4. Sudden cardiac death - Unexpected death from cardiac causesusually within one hour after a cardiac event or without the onset ofsymptoms. Strikes 300,000 - 400,000 persons annually. Usuallyhigh-grade stenosis with acute coronary changes.

    Coronary Artery Disease: Angina Pectoris

  • 8/8/2019 Cardiovascular Diseases Final

    102/119

    CoronaryArtery Disease:Angina Pectoris

    NSG care

    Assessment

    Vital signs

    Activity tolerance

    History of precipitating factors

    Analysis/Nsg diagnosis

    Refer to General Nursing diagnosis for clients with circulatory

    System disorder

    A1 C2 E F

    Coronary Artery Disease: Angina Pectoris

  • 8/8/2019 Cardiovascular Diseases Final

    103/119

    CoronaryArtery Disease:Angina Pectoris

    NSG care

    Planning and implementation

    Provide physical and mental rest

    Relieve pain by administration of vasodilators

    Discourage smoking educate client regarding diet, medicationand activity

    Provide necessary emotional support to the client regardingmodification of life-styles

    Evaluation/outcomes Describes he use of therapeutic medication

    Alters the life style, which contributes to the improvement ofdisease process

    Episodes of pain are decrease in frequency, intensity andduration

  • 8/8/2019 Cardiovascular Diseases Final

    104/119

    Myocardial Infarction

    --IrreversibleIrreversible

    myocardialinjurymyocardialinjury

    duetoprolongedduetoprolongedischemiaischemia

    --Frequently affectsFrequently affects

    theleftventricleduetheleftventricledue

    toincreased worktoincreased workloadload

    M di l I f ti

  • 8/8/2019 Cardiovascular Diseases Final

    105/119

    Myocardial Infarction

    The pathogenesis can include: Occlusive intracoronary thrombus - a thrombus

    overlying an ulcerated or fissured stenotic plaquecauses 90% of transmural acute myocardial

    infarctions. Vasospasm - with or without coronaryatherosclerosis and possible association withplatelet aggregation.

    Emboli - from left sided mural thrombosis,

    vegetative endocarditis, or paradoxic emboli fromthe right side of heart through a patent foramenovale.

    Myocardial Infarction

  • 8/8/2019 Cardiovascular Diseases Final

    106/119

    Myocardial Infarction

    Signs and Symptoms

    Chest pain described as a pressure sensation,fullness, or squeezing in the midportion of thethorax

    Radiation of chest pain into the jaw/teeth,shoulder, arm, and/or back

    Associated dyspnea or shortness of breath

    Associated epigastric discomfort with or withoutnausea and vomiting

    Associated diaphoresis or sweating

    Syncope or near-syncope without other cause Impairment of cognitive function without other

    cause

    Myocardial Infarction

  • 8/8/2019 Cardiovascular Diseases Final

    107/119

    Myocardial Infarction

    diagnostics

    Laboratory DiagnosisofMyocardialInfarction A number of laboratory tests are available. None is

    completely sensitive and specific for myocardial infarction,particularly in the hours following onset of symptoms. Timingis important, as are correlation with patient symptoms,electrocardiograms, and angiographic studies.

    The following tests are available as markers for acutemyocardial infarction: Creatine Kinase- Total:

    Creatine Kinase- MB Fraction:

    CK-MB Isoforms:

    Troponins: Myoglobin:

    Lactatedehydrogenase:

    M di l I f ti C li ti

  • 8/8/2019 Cardiovascular Diseases Final

    108/119

    Myocardial Infarction Complications

    Arrhythmias and conduction defects, with possible "sudden

    death"

    Extension of infarction, or re-infarction

    Congestive heart failure (pulmonary edema)

    Cardiogenic shock

    Pericarditis

    Mural thrombosis, with possible embolization

    Myocardial wall rupture, with possible tamponade

    Papillary muscle rupture, with possible valvular

    insufficiency

    Ventricular aneurysm formation

    Myocardial Infarction

  • 8/8/2019 Cardiovascular Diseases Final

    109/119

    Myocardial Infarction

    Nsg care

    Assessment

    Changes in heart rate, rhythm, and conduction of heartfunction evidenced on electrocardiogram

    Life-threatening dysrhythmias Ventricular fibrillation andasystole

    PVCs close to a T-wave, V-tachycardia,AF

    If these occur, administer prescribed medication, document therhythm

    Vital signs every minute until stable

    Intake and output

    Pulmonary congestion and dependent edema

    Occurrence of chest pain and restlessness

    Cyanosis and dyspnea

    Myocardial Infarction

  • 8/8/2019 Cardiovascular Diseases Final

    110/119

    Myocardial Infarction

    Nsg care

    Planning/Implementation Respond to dysrhythmias with defibrillation,

    cardiac massage, or medications as appropriate Administer drug as ordered Administered oxygen as necessary Recognize that the client is subject to sensory

    overload Orient the unit and machinery] Allow pt time to express feelings and fears

    Provide gradual increase in activity

    Apply anti-embolism stockings Provide emotional support to client and family Reduce anxiety and accept clients fears

    Myocardial Infarction

  • 8/8/2019 Cardiovascular Diseases Final

    111/119

    Myocardial Infarction

    Nsg care

    Evaluation and outcomes

    Pain is reduced

    Adequate tissue perfusion is maintained

    Verbalizes a reduction in anxiety and fear

    Adheres to prescribe regimen (dietary,

    pharmacologic and exercise)

  • 8/8/2019 Cardiovascular Diseases Final

    112/119

    JNC VII (J i t N ti l C itt th

  • 8/8/2019 Cardiovascular Diseases Final

    113/119

    JNC VII (Joint National Committee on the

    Prevention, Detection, Evaluation & Treatment

    ofHigh BP)

    CATEGORY SYSTOLIC DIASTOLIC

    NORMAL /= 100

    P th h i l

  • 8/8/2019 Cardiovascular Diseases Final

    114/119

    Pathophysiology

    Major risk factor

    Smoking, dyslipedemia (elevated LDL [or Total cholesterol and /

    low HDL cholesterol

    Diabetes mellitus

    Impaired renal function (GFR

  • 8/8/2019 Cardiovascular Diseases Final

    115/119

    g g g

    Disease

    Heart disease( left ventricular Hypertrophy,

    angina or previous myocardial infarction,

    previous coronary revascularization, heart

    failure) Stroke (CVA) or TIA

    Chronic kidney disease

    Peripheral arterial disease

    Retinopathy

    Medical mngt

  • 8/8/2019 Cardiovascular Diseases Final

    116/119

    Medical mngt

    Lifestyle modification

    Pharmacologic:

    Thiazides, ACE inhibitors, ARB, BB, CCB, aldosterone antagonist

    sedatives

    Weight reduction Cessation of smoking

    Sodium restricted diet

    Establishment of regular exercise program

    Biofeedback

    Relaxation modalities

    Sympathectomy to dilate arteries

    Hypertension

  • 8/8/2019 Cardiovascular Diseases Final

    117/119

    yp

    NSG care

    Assessment

    Vita signs with client in both upright and

    recumbent positions

    Baseline weight Headache, tinnitus, fatigability, memory loss,

    palpitations

    A

    nalysis/D

    iagnoses Refer to General Nursing diagnosis for clients with circulatorySystem disorder: B1, B2, D, J, K

    Hypertension

  • 8/8/2019 Cardiovascular Diseases Final

    118/119

    yp

    NSG care

    Planning/Implementation Monitor vital signs with client both upright and

    recumbent position

    Weigh client daily

    Pay particular attention to calcium and potassiumintake because HPN has been associated withdeficiencies of these minerals; monitor blood work

    Reassure and support any expression of emotions

    If epistaxis occurs, place an icepack on the back of theneck, which may alleviate it; packing is sometimesrequired

    Hypertension

  • 8/8/2019 Cardiovascular Diseases Final

    119/119

    NSG care

    Educate the client regarding drugs, follow-up care,activity restrictions, and diet; note that many saltsubstitutes contain potassium chloride rather thansodium chloride and may be permitted if client

    has no renal impairment

    Evaluation and outcomes

    Blood pressure is reduced to an acceptable level Understands and adheres to medical regimen

    Verbalizes the need for stress reduction